Back to Search
KEITH BIBLE, M.D., PHD
M.D., PHD
Medical Oncology Physician
NPI: 1497733216Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
33732(MN)
Research & Publications (17)
Phase 1 trial of flavopiridol combined with cisplatin or carboplatin in patients with advanced malignancies with the assessment of pharmacokinetic and pharmacodynamic end points.
PMID 16115936·Clin Cancer Res·2005
3-trial
Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol.
PMID 10690552·Clin Cancer Res·2000
8-other
Stand-level gas-exchange responses to seasonal drought in very young versus old Douglas-fir forests of the Pacific Northwest, USA.
PMID 19502614·Tree Physiol·2009
4-observational
The anticancer agent chaetocin is a competitive substrate and inhibitor of thioredoxin reductase.
PMID 18999987·Antioxid Redox Signal·2009
8-other
A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors.
PMID 17938863·Invest New Drugs·2008
3-trial
Prosurvival function of the granulin-epithelin precursor is important in tumor progression and chemoresponse.
PMID 17266030·Int J Cancer·2007
7-preclinical
Inhibition of mitochondrial respiration as a source of adaphostin-induced reactive oxygen species and cytotoxicity.
PMID 17213201·J Biol Chem·2007
8-other
Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress.
PMID 17090648·Blood·2007
7-preclinical
Dynamics of water transport and storage in conifers studied with deuterium and heat tracing techniques.
PMID 17086757·Plant Cell Environ·2006
8-other
Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity.
PMID 16767218·J Clin Invest·2006
8-other
Flavopiridol in patients with relapsed or refractory multiple myeloma: a phase 2 trial with clinical and pharmacodynamic end-points.
PMID 16503551·Haematologica·2006
3-trial
Flavopiridol disrupts STAT3/DNA interactions, attenuates STAT3-directed transcription, and combines with the Jak kinase inhibitor AG490 to achieve cytotoxic synergy.
PMID 16432172·Mol Cancer Ther·2006
8-other
Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias.
PMID 16322302·Clin Cancer Res·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1497733216
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 17
Are you this provider?
Claim Your Profile